New Horizon Health (HKSE:06606) EV-to-EBIT : 663.94 (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, New Horizon Health's Enterprise Value is HK$4,993 Mil. New Horizon Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$8 Mil. Therefore, New Horizon Health's EV-to-EBIT for today is 663.94.

The historical rank and industry rank for New Horizon Health's EV-to-EBIT or its related term are showing as below:

HKSE:06606' s EV-to-EBIT Range Over the Past 10 Years
Min: -179.2 Med: -30.61 Max: 664.25
Current: 663.94

During the past 5 years, the highest EV-to-EBIT of New Horizon Health was 664.25. The lowest was -179.20. And the median was -30.61.

HKSE:06606's EV-to-EBIT is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 19.78 vs HKSE:06606: 663.94

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. New Horizon Health's Enterprise Value for the quarter that ended in Jun. 2023 was HK$11,172 Mil. New Horizon Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$8 Mil. New Horizon Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 0.07%.

New Horizon Health EV-to-EBIT Historical Data

The historical data trend for New Horizon Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health EV-to-EBIT Chart

New Horizon Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-EBIT

-1.99

-78.59

New Horizon Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-EBIT	Get a 7-Day Free Trial				-115.07	-1.99	-	-78.59	-

Competitive Comparison of New Horizon Health's EV-to-EBIT

For the Medical Devices subindustry, New Horizon Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Horizon Health's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where New Horizon Health's EV-to-EBIT falls into.

New Horizon Health EV-to-EBIT Calculation

New Horizon Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	4993.477	/	7.521
	=	663.94

New Horizon Health's current Enterprise Value is HK$4,993 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. New Horizon Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$8 Mil.

New Horizon Health (HKSE:06606) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

New Horizon Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	7.521	/	11172.35535
	=	0.07 %

New Horizon Health's Enterprise Value for the quarter that ended in Jun. 2023 was HK$11,172 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. New Horizon Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$8 Mil.

New Horizon Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of New Horizon Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

New Horizon Health (HKSE:06606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

6YZ:Germany

Address

400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

https://ir.newhorizonbio.com

New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

Executives

Invesco Advisers, Inc.	2102 Investment manager
Chen Yiyou	2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited	2301 Trustee
Bancasa Holding Limited	2201 Interest of corporation controlled by you
Mst Development Limited	2101 Beneficial owner
Yao Naxin	2305 Beneficiary of a trust
Janus Henderson Group Plc	2102 Investment manager
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Invesco Developing Markets Fund	2106 Person having a security interest in shares
Zhu Yeqing	2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines